<DOC>
	<DOCNO>NCT02902016</DOCNO>
	<brief_summary>This study design assess effect new PPARgamma modulator expression activity lactase enzyme human intestinal epithelial cell . Based previous experimental result , investigator hypothesize modulate intestinal PPARgamma activity new pharmacological mechanism allow control lactase expression activity gut</brief_summary>
	<brief_title>Modulation Lactase Expression New PPARgamma Ligand Duodenal Biopsies</brief_title>
	<detailed_description />
	<mesh_term>Lactose Intolerance</mesh_term>
	<criteria>Subjects undergoing gastroduodenal endoscopy digestive cancer screen Subjects undergoing gastroduodenal endoscopy ulcerative gastroduodenal disease Subjects undergoing gastroduodenal endoscopy epigastric pain Subjects undergoing gastroduodenal endoscopy gastroesophageal reflux diseases Subjects macroscopic duodenal lesion detect endoscopy Subjects suffering coeliac disease Subjects suffer atrophic gastritis Subjects use anticoagulant Pregnancy breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>PPARgamma</keyword>
	<keyword>Lactose intolerance</keyword>
	<keyword>Lactase</keyword>
</DOC>